279 related articles for article (PubMed ID: 16842143)
1. Drug therapies in the secondary prevention of cardiovascular diseases: Successes, shortcomings and future directions.
Lonn E; Grewal J
Curr Vasc Pharmacol; 2006 Jul; 4(3):253-68. PubMed ID: 16842143
[TBL] [Abstract][Full Text] [Related]
2. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
3. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.
Yusuf S; Islam S; Chow CK; Rangarajan S; Dagenais G; Diaz R; Gupta R; Kelishadi R; Iqbal R; Avezum A; Kruger A; Kutty R; Lanas F; Lisheng L; Wei L; Lopez-Jaramillo P; Oguz A; Rahman O; Swidan H; Yusoff K; Zatonski W; Rosengren A; Teo KK;
Lancet; 2011 Oct; 378(9798):1231-43. PubMed ID: 21872920
[TBL] [Abstract][Full Text] [Related]
4. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
5. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
Ferdinand KC
J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
[TBL] [Abstract][Full Text] [Related]
6. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.
; Yusuf S; Pais P; Afzal R; Xavier D; Teo K; Eikelboom J; Sigamani A; Mohan V; Gupta R; Thomas N
Lancet; 2009 Apr; 373(9672):1341-51. PubMed ID: 19339045
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
[TBL] [Abstract][Full Text] [Related]
8. A Step Ahead in Secondary Prevention of Cardiovascular Risk. Consensus Document on Clinical Use of the Polypill.
González-Juanatey JR; Mostaza JM; Lobos JM; Abarca B; Llisterri JL
Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):547-50. PubMed ID: 27062678
[No Abstract] [Full Text] [Related]
9. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
[TBL] [Abstract][Full Text] [Related]
11. Acute ischemic coronary artery disease and ischemic stroke: similarities and differences.
Fisher M; Folland E
Am J Ther; 2008; 15(2):137-49. PubMed ID: 18356634
[TBL] [Abstract][Full Text] [Related]
12. Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study.
Nalini M; Sepanlou SG; Pourshams A; Poustchi H; Sharafkhah M; Bahrami H; Kamangar F; Malekzadeh R
Arch Iran Med; 2018 Mar; 21(3):86-94. PubMed ID: 29688733
[TBL] [Abstract][Full Text] [Related]
13. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.
Feher G; Koltai K; Papp E; Alkonyi B; Solyom A; Kenyeres P; Kesmarky G; Czopf L; Toth K
Drugs Aging; 2006; 23(7):559-67. PubMed ID: 16930084
[TBL] [Abstract][Full Text] [Related]
14. Missed opportunities for the secondary prevention of cardiovascular disease in Canada.
Hackam DG; Leiter LA; Yan AT; Yan RT; Mendelsohn A; Tan M; Zavodni L; Chen R; Tsang JL; Kundi A; Lin PJ; Fitchett DH; Langer A; Goodman SG;
Can J Cardiol; 2007 Dec; 23(14):1124-30. PubMed ID: 18060097
[TBL] [Abstract][Full Text] [Related]
15. Re: Secondary medical prevention in patients with peripheral arterial disease.
Schouten O; Welten GM; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
[No Abstract] [Full Text] [Related]
16. [Changes in the prescription of cardiovascular prevention drugs in France between 1995 and 2003: factors influencing the gap between evidence base medicine and clinical practice].
Philippe F; Cambou JP; Danchin N; Thomas D
Ann Cardiol Angeiol (Paris); 2005 Dec; 54 Suppl 1():S30-6. PubMed ID: 16411649
[TBL] [Abstract][Full Text] [Related]
17. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624
[TBL] [Abstract][Full Text] [Related]
18. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
19. President's page: the promise of prevention: so, why aren't all cardiologists "preventive"?
Wolk MJ; Bairey Merz CN; Thompson PD
J Am Coll Cardiol; 2004 Nov; 44(10):2082-4. PubMed ID: 15542296
[No Abstract] [Full Text] [Related]
20. Implementing guidelines in primary care: can population impact measures help?
Heller RF; Edwards R; McElduff P
BMC Public Health; 2003 Jan; 3():7. PubMed ID: 12542840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]